Četrt stoletja specializacije iz internistične onkologije v Sloveniji A quarter of a century of specialization in medical oncology in Slovenia

Abstract

Sistemsko zdravljenje dokazano izboljša preživetje številnih
bolnikov z rakom. Nabor protirakavih zdravil se je v zadnjih
desetletjih močno povečal, z njimi zdravimo več kot polovico
obolelih. Specifičnost bolezni, specifičnost zdravljenja in zdravil, ki imajo pogosto zelo ozko terapevtsko okno, so zahtevale razvoj nove, od klasične interne medicine ločene specializacije, internistične onkologije. Specializacija iz internistične onkologije je kot samostojna veja specializacije iz interne medicine v Sloveniji priznana od leta 2000. Pojavnost raka v Sloveniji narašča, vse več je bolnikov, ki potrebujejo tudi sistemsko zdravljenje in obravnavo pri internistu onkologu. Žal pa skladno z rastjo števila bolnikov ne raste tudi število internistov onkologov, premajhne postajajo tudi obstoječe prostorske zmogljivosti.

Abstract (Eng)

Systemic therapy has been shown to improve survival in many cancer patients. The number of anticancer drugs has increased dramatically in recent decades and more than half of all cancer patients are treated with these drugs. The specificity of the disease, the specificity of the treatment, and the drugs, which often have a very narrow therapeutic window, have necessitated the development of a new specialty, medical oncology, separate from internal medicine. Since 2000, medical oncology has been recognized in Slovenia as an independent specialization separate from internal medicine. The incidence of cancer in Slovenia is increasing, and there are more and more patients who need systemic treatment and management by medical oncologists. Unfortunately, the number of oncologists is not increasing at the same rate as the number of patients, and the existing facilities are becoming inadequate.